Risk classification based on histopathologic features is an effective approach to selecting appropriate adjuvant therapy for patients with intraocular unilateral retinoblastoma treated by primary enucleation, according to a study published online March 5 in the Journal of Clinical Oncology .
http://www.mentalhelp.net/poc/view_doc.php?type=news&id=153581&cn=26
http://www.mentalhelp.net/poc/view_doc.php?type=news&id=153581&cn=26
No comments:
Post a Comment